65,437 trials
Aphasia · Non-fluent Aphasia · Stroke
Primary: Discourse: Picture Description — 10; 5.66 score on a scale
Healthy Male and Female Subjects
Primary: Proprioception — 54; 62.8; 86.7; 85.3 mm
Schizophrenia · Dual Diagnosis · Psychotic Disorder
Primary: Brain Reward Circuit Activation on fMRI Scan — 0.05; 0.14; 0.18; 0.12 z-score — p=0.87
Metastatic Melanoma
Primary: Disease Assessment for Objective Response Rate — 4; 23; 1; 25 Participants
Atrophic Vaginitis · Breast Cancer
Primary: Change in Serum Estradiol From Baseline to Week 12 — 5.21; 4.46; 5.23; 6.72 pg/ml
Smoking Behaviors · Cigarette Smoking
Primary: Nicotine Beliefs — 7.5; 8.1; 5.3; 4.8 score on a scale — p=0.0008
Substance Abuse
Primary: Number of Participants With Positive Urine Drug Screens at 5 Months Post-baseline — 18; 13 participants
Cutaneous Melanoma
Primary: Change in Clinician Knowledge in Melanoma Risk and Lesion Identification — 72.1; 80.8 score on a scale — p=0.05
Graft Versus Host Disease
Primary: Distribution of Acute GVHD Grades (MAGIC Criteria) at Time of PET/CT Scan — 0; 2; 0; 0 Participants
Autism · Attention Deficit Hyperactivity Disorder
Primary: Change From Baseline in Attention Deficit Hyperactivity Disorder Symptom Checklist (ADHD-SCL) — -8.5 change in scale score
Atypical Hemolytic Uremic
Primary: Percentage of Participants With a Complete Thrombotic Microangiopathy (TMA) Response — 64.0 percentage of participants
Suppression of Ovulation
Primary: Number of Days Bleeding is Reported. — 34.0; 42.1; 39.8; 14.7 Days
Peripheral Arterial Disease
Primary: Walking Distance — 375; 411; 405; 425 meters — p=0.38
Exercise · Renal Dialysis · Anxiety
Primary: Change in Depression Score (PHQ-9) From Baseline to 6 Months. — 2.96; 8.00 Unit on a scale. — p=0.05
Diabetes Mellitus, Type 2
Primary: Frequency of Eating in Response to Cravings (Primary Mechanistic Outcome) — -20.39; -25.27 % of EMAs with craving related eating